Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
Ongoing low-dose maintenance (experimental) Continuous dosing approach: Dose: 1-2mg daily OR 3-5mg 2-3x weekly Duration: Ongoing (not cycled) Goal: Maintain constant telomerase activation Status: Experimental, not from research protocols Rationale: Telomerase needs continuous activation to maintain telomere length Cyclic dosing may allow regression between cycles Low-dose continuous might provide stable benefits Similar to maintenance protocols for other peptides Continuous dosing options: Advantages of continuous: No "off" periods where benefits regress Potentially stronger cumulative anti-aging More like natural physiologic regulation Easier to stack with other peptides Disadvantages: Much higher annual cost ($1,800-3,600 vs $300-600) No long-term safety data Uncertain if better than cyclic approach Storage challenges (more reconstitution) Deviates from proven protocols Current recommendation: Stick with proven 10-day cycles for most users Consider continuous only if cyclic approach inadequate Start with standard protocol first Assess your individual response Consult with peptide-knowledgeable physician Use our peptide cycle planning guide to design your Epithalon protocol
This specific combination is designed to aggressively target the neuroinflammation and sympathetic nervous system overactivity that drives dysautonomia and POTS
What the Clinical Evidence Actually Shows This is where the conversation has to get more careful
Aberrant tonic inhibition of dopaminergic neuronal activity causes motor symptoms in animal models of Parkinsons disease
In contrast, our minimally invasive approach to hair restoration calls for little to no downtime, with many patients resuming their usual routines within a day of treatment
PMID: 36163775
